Abeshouse, A. et al. The molecular taxonomy of major prostate most cancers. Cell 163, 1011–1025 (2015).
Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346–1351 (2015).
Armenia, J. et al. The lengthy tail of oncogenic drivers in prostate most cancers. Nat. Genet. 50, 645–651 (2018).
Quigley, D. A. et al. Genomic hallmarks and structural variation in metastatic prostate most cancers. Cell 174, 758–769 (2018).
Zhao, S. G. et al. The DNA methylation panorama of superior prostate most cancers. Nat. Genet. 52, 778–789 (2020).
Sjöström, M. et al. The 5-hydroxymethylcytosine panorama of prostate most cancers. Most cancers Res. 82, 3888–3902 (2022).
Robinson, D. et al. Integrative medical genomics of superior prostate most cancers. Cell 161, 1215–1228 (2015).
Grasso, C. S. et al. The mutational panorama of deadly castration-resistant prostate most cancers. Nature 487, 239–243 (2012).
Kumar, A. et al. Substantial interindividual and restricted intraindividual genomic range amongst tumors from males with metastatic prostate most cancers. Nat. Med. 22, 369–378 (2016).
Pomerantz, M. M. et al. Prostate most cancers reactivates developmental epigenomic packages throughout metastatic development. Nat. Genet. 52, 790–799 (2020).
Takeda, D. Y. et al. A somatically acquired enhancer of the androgen receptor is a noncoding driver in superior prostate most cancers. Cell 174, 422–432 (2018).
Viswanathan, S. R. et al. Structural alterations driving castration-resistant prostate most cancers revealed by linked-read genome sequencing. Cell 174, 433–447 (2018).
Krijger, P. H. & de Laat, W. Regulation of disease-associated gene expression within the 3D genome. Nat. Rev. Mol. Cell Biol. 17, 771–782 (2016).
Ntziachristos, P., Abdel-Wahab, O. & Aifantis, I. Rising ideas of epigenetic dysregulation in hematological malignancies. Nat. Immunol. 17, 1016–1024 (2016).
Lieberman-Aiden, E. et al. Complete mapping of long-range interactions reveals folding ideas of the human genome. Science 326, 289–293 (2009).
Beagan, J. A. & Phillips-Cremins, J. E. On the existence and performance of topologically associating domains. Nat. Genet. 52, 8–16 (2020).
Javierre, B. M. et al. Lineage-specific genome structure hyperlinks enhancers and non-coding illness variants to focus on gene promoters. Cell 167, 1369–1384 (2016).
Hawley, J. R. et al. Reorganization of the 3D genome pinpoints noncoding drivers of major prostate tumors. Most cancers Res. 81, 5833–5848 (2021).
Dunham, I. et al. An built-in encyclopedia of DNA parts within the human genome. Nature 489, 57–74 (2012).
Díaz, N. et al. Chromatin conformation evaluation of major affected person tissue utilizing a low enter Hello-C technique. Nat. Commun. 9, 4938 (2018).
Li, T. et al. Integrative evaluation of genome, 3D genome, and transcriptome alterations of medical lung most cancers samples. Genomics Proteomics Bioinformatics 19, 741–753 (2021).
Animesh, S. et al. Profiling of 3D genome group in nasopharyngeal most cancers needle biopsy affected person samples by a modified Hello-C strategy. Entrance. Genet. 12, 673530 (2021).
Yang, Y. et al. Excessive-throughput chromosome conformation capture-based evaluation of higher-order chromatin construction in nasopharyngeal carcinoma. Ann. Transl. Med. 9, 1314 (2021).
Wang, J. et al. Epigenomic panorama and 3D genome construction in pediatric high-grade glioma. Sci. Adv. 7, eabg4126 (2021).
Kloetgen, A. et al. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nat. Genet. 52, 388–400 (2020).
Yang, L. et al. 3D genome alterations related to dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia. Nat. Commun. 12, 3708 (2021).
Johnstone, S. E. et al. Massive-scale topological adjustments restrain malignant development in colorectal most cancers. Cell 182, 1474–1489 (2020).
Xu, J. et al. Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature 611, 387–398 (2022).
Buitrago, D. et al. Impression of DNA methylation on 3D genome construction. Nat. Commun. 12, 3243 (2021).
Du, Q. et al. DNA methylation is required to keep up each DNA replication timing precision and 3D genome group integrity. Cell Rep. 36, 109722 (2021).
Fortin, J.-P. & Hansen, Okay. D. Reconstructing A/B compartments as revealed by Hello-C utilizing long-range correlations in epigenetic knowledge. Genome Biol. 16, 180 (2015).
Berman, B. P. et al. Areas of focal DNA hypermethylation and long-range hypomethylation in colorectal most cancers coincide with nuclear lamina-associated domains. Nat. Genet. 44, 40–46 (2011).
Briand, N. & Collas, P. Lamina-associated domains: peripheral issues and inside affairs. Genome Biol. 21, 85 (2020).
Makova, Okay. D. & Hardison, R. C. The consequences of chromatin group on variation in mutation charges within the genome. Nat. Rev. Genet. 16, 213–223 (2015).
Schuster-Böckler, B. & Lehner, B. Chromatin group is a serious affect on regional mutation charges in human most cancers cells. Nature 488, 504–507 (2012).
Akdemir, Okay. C. et al. Somatic mutation distributions in most cancers genomes fluctuate with three-dimensional chromatin construction. Nat. Genet. 52, 1178–1188 (2020).
Kim, H. et al. Extrachromosomal DNA is related to oncogene amplification and poor consequence throughout a number of cancers. Nat. Genet. 52, 891–897 (2020).
Keshavarzian, T. & Lupien, M. ecDNAs personify most cancers gangsters. Mol. Cell 82, 500–502 (2022).
Prensner, J. R. et al. The lengthy noncoding RNA SChLAP1 promotes aggressive prostate most cancers and antagonizes the SWI/SNF complicated. Nat. Genet. 45, 1392–1398 (2013).
Prensner, J. R. et al. RNA biomarkers related to metastatic development in prostate most cancers: a multi-institutional high-throughput evaluation of SChLAP1. Lancet Oncol. 15, 1469–1480 (2014).
Servant, N., Varoquaux, N., Heard, E., Barillot, E. & Vert, J.-P. Efficient normalization for copy quantity variation in Hello-C knowledge. BMC Bioinformatics 19, 313 (2018).
Wu, S. et al. Round ecDNA promotes accessible chromatin and excessive oncogene expression. Nature 575, 699–703 (2019).
Zivanovic, A. et al. Co-evolution of AR gene copy quantity and structural complexity in endocrine remedy resistant prostate most cancers. NAR Most cancers 5, zcad045 (2023).
Aggarwal, R. et al. Prognosis related to luminal and basal subtypes of metastatic prostate most cancers. JAMA Oncol. 7, 1644–1652 (2021).
Lancho, O. & Herranz, D. The MYC enhancer-ome: long-range transcriptional regulation of MYC in most cancers. Developments Most cancers 4, 810–822 (2018).
Parolia, A. et al. Distinct structural courses of activating FOXA1 alterations in superior prostate most cancers. Nature 571, 413–418 (2019).
Schuijers, J. et al. Transcriptional dysregulation of MYC reveals frequent enhancer-docking mechanism. Cell Rep. 23, 349–360 (2018).
Cho, S. W. et al. Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary ingredient. Cell 173, 1398–1412 (2018).
Ramanand, S. G. et al. The panorama of RNA polymerase II-associated chromatin interactions in prostate most cancers. J. Clin. Make investments. 130, 3987–4005 (2020).
Matejcic, M. et al. Germline variation at 8q24 and prostate most cancers danger in males of European ancestry. Nat. Commun. 9, 4616 (2018).
Dixon, J. R. et al. Integrative detection and evaluation of structural variation in most cancers genomes. Nat. Genet. 50, 1388–1398 (2018).
Nikiforova, M. N. et al. Proximity of chromosomal loci that take part in radiation-induced rearrangements in human cells. Science 290, 138–141 (2000).
Zhang, Y. et al. Spatial group of the mouse genome and its position in recurrent chromosomal translocations. Cell 148, 908–921 (2012).
Mani, R.-S. et al. Induced chromosomal proximity and gene fusions in prostate most cancers. Science 326, 1230 (2009).
San Martin, R. et al. Chromosome compartmentalization alterations in prostate most cancers cell traces mannequin illness development. J. Cell Biol. 221, e202104108 (2022).
Morton, A. R. et al. Useful enhancers form extrachromosomal oncogene amplifications. Cell 179, 1330–1341 (2019).
van Leen, E., Brückner, L. & Henssen, A. G. The genomic and spatial mobility of extrachromosomal DNA and its implications for most cancers remedy. Nat. Genet. 54, 107–114 (2022).
Oobatake, Y. & Shimizu, N. Double-strand breakage within the extrachromosomal double minutes triggers their aggregation within the nucleus, micronucleation, and morphological transformation. Genes Chromosomes Most cancers 59, 133–143 (2020).
Shoshani, O. et al. Chromothripsis drives the evolution of gene amplification in most cancers. Nature 591, 137–141 (2021).
Rhie, S. Okay. et al. A high-resolution 3D epigenomic map reveals insights into the creation of the prostate most cancers transcriptome. Nat. Commun. 10, 4154 (2019).
Lourenco, C. et al. MYC protein interactors in gene transcription and most cancers. Nat. Rev. Most cancers 21, 579–591 (2021).
Patange, S. et al. MYC amplifies gene expression via international adjustments in transcription issue dynamics. Cell Rep. 38, 110292 (2022).
Amjadi-Moheb, F., Paniri, A. & Akhavan-Niaki, H. Insights into the hyperlinks between MYC and 3D chromatin construction and epigenetics regulation: implications for most cancers remedy. Most cancers Res. 81, 1925–1936 (2021).
Hyle, J. et al. Acute depletion of CTCF immediately impacts MYC regulation via lack of enhancer-promoter looping. Nucleic Acids Res. 47, 6699–6713 (2019).
Chen, W. S. et al. Germline polymorphisms related to impaired survival outcomes and somatic tumor alterations in superior prostate most cancers. Prostate Most cancers Prostatic Dis. 23, 316–323 (2020).
Servant, N. et al. HiC-Professional: an optimized and versatile pipeline for Hello-C knowledge processing. Genome Biol. 16, 259 (2015).
Langmead, B. & Salzberg, S. L. Quick gapped-read alignment with Bowtie 2. Nat. Strategies 9, 357–359 (2012).
Imakaev, M. et al. Iterative correction of Hello-C knowledge reveals hallmarks of chromosome group. Nat. Strategies 9, 999–1003 (2012).
Shin, H. et al. TopDom: an environment friendly and deterministic technique for figuring out topological domains in genomes. Nucleic Acids Res. 44, e70 (2016).
Servant, N. et al. HiTC: exploration of high-throughput ‘C’ experiments. Bioinformatics 28, 2843–2844 (2012).
Boltsis, I., Grosveld, F., Giraud, G. & Kolovos, P. Chromatin conformation in growth and illness. Entrance. Cell Dev. Biol. 9, 723859 (2021).
Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic stable tumours. Nature 575, 210–216 (2019).
Kim, S. et al. Strelka2: quick and correct calling of germline and somatic variants. Nat. Strategies 15, 591–594 (2018).
Cibulskis, Okay. et al. Delicate detection of somatic level mutations in impure and heterogeneous most cancers samples. Nat. Biotechnol. 31, 213–219 (2013).
Chen, X. et al. Manta: fast detection of structural variants and indels for germline and most cancers sequencing purposes. Bioinformatics 32, 1220–1222 (2016).
Shale, C. et al. Unscrambling most cancers genomes by way of built-in evaluation of structural variation and replica quantity. Cell Genom. 2, 100112 (2022).
Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
Hadi, Okay. et al. Distinct courses of complicated structural variation uncovered throughout 1000’s of most cancers genome graphs. Cell 183, 197–210 (2020).
Krueger, F. & Andrews, S. R. Bismark: a versatile aligner and methylation caller for Bisulfite-Seq purposes. Bioinformatics 27, 1571–1572 (2011).
Burger, L., Gaidatzis, D., Schübeler, D. & Stadler, M. B. Identification of energetic regulatory areas from DNA methylation knowledge. Nucleic Acids Res. 41, e155 (2013).
Dobin, A. et al. STAR: ultrafast common RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic areas of the genome. Sci. Rep. 9, 9354 (2019).
Zhang, Y. et al. Mannequin-based evaluation of ChIP–Seq (MACS). Genome Biol. 9, R137 (2008).
Samb, R. et al. Utilizing informative Multinomial-Dirichlet prior in a t-mixture with reversible bounce estimation of nucleosome positions for genome-wide profiling. Stat. Appl. Genet. Mol. Biol. 14, 517–532 (2015).
Zhang, Z. et al. An AR-ERG transcriptional signature outlined by long-range chromatin interactomes in prostate most cancers cells. Genome Res. 29, 223–235 (2019).
